Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Post-approval studies (Phase 4)Study completedNCT02178306
What this trial is testing

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

Who this might be right for
Hypertension
Boehringer Ingelheim 82
Early research (Phase 1)Study completedNCT01613690
What this trial is testing

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT02219516
What this trial is testing

Mild, Moderate and Severe Renal Impairment Study

Who this might be right for
Gout
Ardea Biosciences, Inc. 31
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Testing effectiveness (Phase 2)UnknownNCT03647384
What this trial is testing

Guilingji Capsule for Mild-to-moderate Cognitive Impairment

Who this might be right for
Cognitive Dysfunction
Xiyuan Hospital of China Academy of Chinese Medical Sciences 348
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Not applicableStudy completedNCT00354588
What this trial is testing

Arterial Stiffness, Wave Reflections and Renal Failure

Who this might be right for
Chronic Renal FailureArterial StiffnessArterial Wave Reflections
Klinikum Wels-Grieskirchen 115
Early research (Phase 1)Study completedNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 35
Early research (Phase 1)Study completedNCT02653014
What this trial is testing

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
KBP Biosciences 26
Early research (Phase 1)Study completedNCT02807077
What this trial is testing

PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects

Who this might be right for
Myelofibrosis
CTI BioPharma 40
Post-approval studies (Phase 4)Study completedNCT00369382
What this trial is testing

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Who this might be right for
Graft RejectionKidney Failure
Wyeth is now a wholly owned subsidiary of Pfizer 121
Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT00543075
What this trial is testing

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Who this might be right for
Normal Renal FunctionMildly Impaired Renal FunctionModerately Impaired Renal Function
Genta Incorporated 23
Early research (Phase 1)Study completedNCT03890770
What this trial is testing

Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

Who this might be right for
Renal ImpairmentHealthy Volunteer
Bristol-Myers Squibb 44
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Early research (Phase 1)Study completedNCT00554450
What this trial is testing

Renal Impairment in Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 40
Testing effectiveness (Phase 2)Ended earlyNCT04987294
What this trial is testing

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Who this might be right for
HyperuricemiaGoutChronic Kidney Diseases
Allena Pharmaceuticals 19
Early research (Phase 1)Study completedNCT06775834
What this trial is testing

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 24
Next Page